Likewise, the potential use of Gal-3 as a predictive marker of therapy response also emerged from proteomics analysis studies carried out in rectal cancer patients showing Gal-3 protein downregulation in rectal tissues after radiation treatment [60]. Here, LGALS3 is linked to rectal cancer.